Jonathan D. Schoenfeld

Stereotactic Body Radiotherapie With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor–Refractory Recurrent or Gemetastaseerd Hoofd-hals Squamous Cell Carcinoma: A Fase 2-Trial

Precision in Practice: A Critical Overview of Recent Advances in Nasopharyngeal Cancer Management